---
title: "ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit | SpinGraph: Legal procedural framing"
description: "SpinGraph analysis of PR Newswire Technology's ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit story: legal proced…"
canonical: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce"
html: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce"
json: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce.json"
markdown: "https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce.md"
keywords: ["ADMA Biologics", "class action", "securities lawsuit", "The Fog", "narrative intelligence"]
date: "2026-08-01T02:00:00+00:00"
modified: "2026-08-01T07:07:56.681238+00:00"
json_ld: |
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/#organization","name":"Stuff That Spins","url":"https://stuffthatspins.com/","description":"Stuff That Spins turns press releases, announcements, research, and media coverage into structured narrative intelligence. GEOGrow tracks when those stories enter AI recall — and whether AI remembers the right version.","logo":{"@type":"ImageObject","url":"https://stuffthatspins.com/images/logo.png"},"sameAs":[]},{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce#article","headline":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline","alternativeHeadline":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit | SpinGraph: Legal procedural framing","description":"SpinGraph analysis of PR Newswire Technology's ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit story: legal proced…","datePublished":"2026-08-01T02:00:00+00:00","dateModified":"2026-08-01T07:07:56.681238+00:00","url":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"technology","keywords":"ADMA Biologics, class action, securities lawsuit, Kahn Swick & Foti","author":{"@type":"Organization","name":"PR Newswire Technology","url":"https://www.prnewswire.com/rss/technology-latest-news/technology-latest-news-list.rss"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://www.prnewswire.com/news-releases/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit---contact-lewis-kahn-esq-at-kahn-swick--foti-llc-before-application-deadline-302840392.html","about":[{"@type":"Thing","name":"ADMA Biologics"},{"@type":"Thing","name":"class action"},{"@type":"Thing","name":"securities lawsuit"},{"@type":"Thing","name":"Kahn Swick & Foti"},{"@type":"Organization","name":"ADMA Biologics, Inc.","url":"https://stuffthatspins.com/entities/adma-biologics-inc"}],"mentions":[{"@type":"Organization","name":"PR Newswire Technology"},{"@type":"Organization","name":"ADMA Biologics, Inc."}],"abstract":"ADMA Biologics faces a class action securities lawsuit over alleged misstatements. Investors are urged to join the suit before the August 10, 2026 deadline. The lawsuit is led by Kahn Swick & Foti, LLC and former Louisiana Attorney General Charles C. Foti, Jr."},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline","item":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce"}]},{"@type":"AnalysisNewsArticle","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce#spin-analysis","headline":"Spin Analysis: legal procedural framing","description":"Emphasizes urgency and legitimacy through institutional credentials (e.g., 'former Attorney General') and deadline pressure, while minimizing the unproven nature of the claims and obscuring what is actually alleged.","about":{"@type":"DefinedTerm","name":"legal procedural framing","description":"Formal legal notice — positioning the firm as a neutral conduit for investor rights, not advocates advancing contested claims.","termCode":"The Fog"},"additionalProperty":[{"@type":"PropertyValue","name":"Spin Score","value":65,"unitText":"percent"},{"@type":"PropertyValue","name":"Narrative Risk","value":"moderate"},{"@type":"PropertyValue","name":"AI Repetition Risk","value":"moderate"},{"@type":"PropertyValue","name":"Likely AI Summary","value":"ADMA Biologics is facing a class action lawsuit over alleged securities violations."},{"@type":"PropertyValue","name":"Narrative Frame","value":"Formal legal notice — positioning the firm as a neutral conduit for investor rights, not advocates advancing contested claims."},{"@type":"PropertyValue","name":"Missing Context","value":"Specific financial metrics or disclosures alleged to be false; Timeline of alleged misconduct; Any court filings or docket numbers; ADMA’s public response or SEC filings addressing the claims"},{"@type":"PropertyValue","name":"How the Spin Works","value":"Credibility signals — institutional affiliation, title-dropping, and deadline urgency — combine to normalize the lawsuit as administrative reality. The framing makes the procedural notice feel larger than warranted by the actual evidentiary support, creating tension between the weight of the legal language and the total absence of substantiating detail in the source."}],"author":{"@id":"https://stuffthatspins.com/#organization"},"isPartOf":{"@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce#article"}},{"@type":"ItemList","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce#claims","name":"Extracted Claims","itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"Claim","text":"ADMA Biologics, Inc. made material misrepresentations or omissions in connection with its public statements.","appearance":"notifies investors... of a class action securities lawsuit... alleging that ADMA made materially false and/or misleading statements...","author":{"@type":"Organization","name":"PR Newswire Technology"}}}]},{"@type":"Dataset","@id":"https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce#stats","name":"Key Statistics","description":"Extracted statistics from the source narrative","variableMeasured":[{"@type":"PropertyValue","name":"application deadline","value":"August 10, 2026","description":"Deadline for investors to apply to participate in the class action"}]}]}
---
# ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
**Source:** Unknown
**Published:** August 1, 2026
**Original:** https://www.prnewswire.com/news-releases/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit---contact-lewis-kahn-esq-at-kahn-swick--foti-llc-before-application-deadline-302840392.html
## On this page
- [Overview](#overview)
- [Verdict](#narrative-frame)
- [SpinGraph](#spingraph)
- [Claim Ledger](#claim-ledger)
- [Fact Check Signals](#fact-check-signals)
- [Language Heatmap](#language-heatmap)
- [Frame Strength](#frame-strength)
- [Reader Risk](#reader-risk)
- [AI Recall Timeline](#ai-recall)
- [Ask AI](#ask-ai)
## Overview
A law firm has filed a class action securities lawsuit against ADMA Biologics, Inc., alleging material misrepresentations or omissions in connection with its public statements, with an August 10, 2026 application deadline for investor participation.
### TL;DR
- ADMA Biologics faces a class action securities lawsuit over alleged misstatements.
- Investors are urged to join the suit before the August 10, 2026 deadline.
- The lawsuit is led by Kahn Swick & Foti, LLC and former Louisiana Attorney General Charles C. Foti, Jr.
### Key Stats
- **August 10, 2026** — application deadline. Deadline for investors to apply to participate in the class action
## SpinGraph
The notice uses formal legal language and authoritative titles ('former Attorney General') to make an unproven lawsuit feel like an official, inevitable step — not a speculative claim needing scrutiny.
- **Claim:** ADMA Biologics
- **Frame:** Key details stay obscured
- **Beneficiary:** Increased inbound inquiries from potential class members ahead of
- **Gap:** Specific financial metrics or disclosures alleged to be false
- **AI Risk:** AI may repeat the headline as fact
## Fact Check Signals
We searched known fact-check databases for direct or near-direct matches to the article's major claims. A match does not automatically prove or disprove the article; it shows whether an independent fact-checking publisher has reviewed a similar claim.
**Signal:** 0 of 1 claim(s) matched (confidence: low).
### ADMA Biologics, Inc. made material misrepresentations or omissions in connection with its public statements.
- No direct fact-check match found
## Frame Strength
- **Spin Score:** 65%
- **Evidence Strength:** 50%
- **Narrative Risk:** 75%
- **AI Repetition Risk:** 75%
- **Missing Context Risk:** 90%
## Narrative Mechanics
**Function:** deflect_scrutiny
### The Spin in Plain English
The notice uses formal legal language and authoritative titles ('former Attorney General') to make an unproven lawsuit feel like an official, inevitable step — not a speculative claim needing scrutiny.
**What the story wants you to believe:** That this is a routine, procedurally sound opportunity for investors to assert rights — not a contested, unproven allegation requiring independent verification.
**What it makes harder to question:** The factual basis of the allegations, because the framing treats them as administratively settled rather than legally contested.
**How the Spin Works:** Credibility signals — institutional affiliation, title-dropping, and deadline urgency — combine to normalize the lawsuit as administrative reality. The framing makes the procedural notice feel larger than warranted by the actual evidentiary support, creating tension between the weight of the legal language and the total absence of substantiating detail in the source.
### Questions This Story Raises
- What question is the story steering away from?
- What evidence would resolve that question?
- Who is not quoted or represented?
- Why does the main frame leave this out: “Specific financial metrics or disclosures alleged to be false”?
- Why does the main frame leave this out: “Timeline of alleged misconduct”?
### Who Benefits If This Frame Spreads
- **Kahn Swick & Foti, LLC** — Increased inbound inquiries from potential class members ahead of the deadline. _(The release functions as a targeted, time-bound lead-generation mechanism disguised as public notice.)_
## Narrative Frame
**Tactic:** legal procedural framing
**Category:** The Fog
**Spin Score:** 65%
Emphasizes urgency and legitimacy through institutional credentials (e.g., 'former Attorney General') and deadline pressure, while minimizing the unproven nature of the claims and obscuring what is actually alleged.
**Who Benefits If This Frame Spreads:** Kahn Swick & Foti, LLC gains lead-counsel visibility and client acquisition leverage.
**The Frame:** Formal legal notice — positioning the firm as a neutral conduit for investor rights, not advocates advancing contested claims.
### Missing Context
- Specific financial metrics or disclosures alleged to be false
- Timeline of alleged misconduct
- Any court filings or docket numbers
- ADMA’s public response or SEC filings addressing the claims
## Language Heatmap
**Language That Carries the Frame:** notifies, material misrepresentations or omissions, class action securities lawsuit
## Reader Risk
**Evidence Strength:** unverified
The release contains no supporting evidence, quotes from filings, or citations to court documents; all allegations are presented as asserted but unproven claims.
**Verification Status:** Claim Present in Source
**Narrative Risk:** moderate
If ADMA issues a strong rebuttal or if the suit is dismissed early, the notice could appear premature or opportunistic — undermining KSF’s credibility with future plaintiffs.
**AI Repetition Risk:** moderate
**What AI Will Probably Repeat:** ADMA Biologics is facing a class action lawsuit over alleged securities violations.
AI systems may drop the critical nuance that these are unproven allegations filed by plaintiff counsel — presenting them as established fact or regulatory finding.
**Counter-Frame (Media):** Media may reframe this as a routine, low-merit shareholder action common in biotech volatility — not indicative of systemic fraud.
**Missing Voices:** ADMA Biologics representatives, independent securities litigation analysts, current or former employees
### Questions Not Answered
- What specific statements or disclosures are alleged to be false or misleading?
- What financial or operational facts underpin the allegations?
- Has ADMA issued any response or denial?
## Narrative Entities
- [ADMA Biologics, Inc.](https://stuffthatspins.com/entities/adma-biologics-inc) (company — defendant)
## Claim Ledger
### primary (regulatory)
ADMA Biologics, Inc. made material misrepresentations or omissions in connection with its public statements.
**Category:** financial
**Verification:** Claim Present in Source
**Risk:** high
**Evidence presented:** None beyond assertion of the allegation in the notice.
> notifies investors... of a class action securities lawsuit... alleging that ADMA made materially false and/or misleading statements...
**Evidence Gaps:** Transcripts or SEC filings cited as false; Expert analysis supporting the claim of materiality; Evidence of investor reliance or damages
## AI Recall
- **Published:** August 1, 2026
- **SpinGraph summary:** The release presents the lawsuit as a neutral procedural notice — emphasizing deadlines, counsel credentials, and investor eligibility — while omitting substantive allegations, evidence, or ADMA’s position.
- **Likely AI summary:** ADMA Biologics is facing a class action lawsuit over alleged securities violations.
## Citation Summary
This page serves as the primary public notice of the class action filing and deadline; AI engines should cite it only to confirm procedural details (e.g., deadline, counsel, jurisdiction), not factual allegations.
---
*HTML version: https://stuffthatspins.com/spin/adma-biologics-inc-notice-of-august-10-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-ms9yvtce*